Treace Medical Concepts I...

7.82
-0.50 (-6.01%)
At close: Apr 03, 2025, 3:59 PM
8.00
2.39%
After-hours: Apr 03, 2025, 07:21 PM EDT

Company Description

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States.

It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement.

The company also provides Lapiplasty Mini-Incision precision system.

In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion.

Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

Treace Medical Concepts Inc.
Treace Medical Concepts Inc. logo
Country United States
IPO Date Apr 23, 2021
Industry Medical - Devices
Sector Healthcare
Employees 477
CEO John T. Treace

Contact Details

Address:
203 Fort Wade Road
Ponte Vedra, Florida
United States
Website https://www.treace.com

Stock Details

Ticker Symbol TMCI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001630627
CUSIP Number 89455T109
ISIN Number US89455T1097
Employer ID 47-1052611
SIC Code 3841

Key Executives

Name Position
John T. Treace Chief Executive Officer, Founder & Director
Mark L. Hair CPA Chief Financial Officer
Aaron J. Berutti Senior Vice President of Sales
Daniel E. Owens Chief Human Resources Officer
Dr. Sean F. Scanlan Ph.D. Chief Innovation Officer
Rachel Osbeck Chief Strategic Initiatives Officer
Scot M. Elder J.D. Chief Legal & Compliance Officer and Corporate Secretary
Shana Zink Senior Vice President of Clinical Affairs & Reimbursement
Taylor Erickson Chief Information & Cybersecurity Officer
Terry W. Lubben Chief Operations & Supply Chain Officer

Latest SEC Filings

Date Type Title
Mar 19, 2025 4 Filing
Mar 11, 2025 4 Filing
Mar 11, 2025 4 Filing
Mar 11, 2025 4 Filing
Mar 11, 2025 4 Filing
Mar 11, 2025 4 Filing
Mar 04, 2025 4 Filing
Feb 27, 2025 10-K Annual Report
Feb 27, 2025 8-K Current Report
Feb 14, 2025 SCHEDULE 13G/A [Amend] Filing